Published online before print August 28, 2003, doi: 10.1161/01.STR.0000089017.90037.7A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2361.)
© 2003 American Heart Association, Inc.
Original Contributions |
Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis
From the Division of Neurology, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong, SAR.
Correspondence to Dr Ka Sing Wong, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, SAR. E-mail ks-wong{at}cuhk.edu.hk
Background and Purpose— The goal of this study was to document the long-term outcome of ischemic stroke patients in a population with predominant intracranial atherosclerosis and risk factors for a recurrent event.
Methods— Intracranial and extracranial arteries of consecutive patients with acute ischemic stroke were studied prospectively with transcranial Doppler and duplex ultrasound. All patients were followed up regularly for the development of recurrent stroke, cardiac event, or death.
Results— We included 705 patients with acute ischemic stroke, of whom 345 were documented ultrasonographically as having large-artery lesions. The follow-up period was up to 42 months (mean, 28±5 months). One hundred seventeen patients (17%) died of any cause, and 199 (28%) suffered further cerebrovascular cardiac events. The 3.5-year cumulative mortality rate was 20.8%; for cerebrovascular event, it was 29.5%. The annual recurrent stroke rates during the first year were 10.9% for patients without vascular lesion, 17.1% for intracranial atherosclerosis only, and 24.3% for both intracranial and extracranial atherosclerosis; for the second year, the rates were 7.5%, 8.6%, and 7.7%, respectively. More occurrence of death (log rank, 5.19; P=0.02) or cerebrovascular event (log rank, 9.68; P=0.002) was found among patients with than those without vascular lesions. Patients with both intracranial and extracranial arterial lesions were at highest risk of death (log rank, 9.64; P=0.008) and cerebrovascular event (log rank, 11.56; P=0.003). When death and further vascular event were combined as poor outcomes in a Cox proportional-hazards regression model, number of abnormal arteries, advanced age, diabetes, atrial fibrillation, and previous stroke were significant predictors.
Conclusions— Patients with intracranial atherosclerosis, especially coexisting extracranial carotid disease, are at higher risk of suffering death or further vascular event. Our findings provide important data for planning future randomized clinical trials for this high-risk group of stroke patients.
Key Words: epidemiology • intracranial arteriosclerosis • prognosis • stroke • ultrasonography, Doppler, transcranial
This article has been cited by other articles:
 |
|
 |
|
  M. N. Nguyen-Huynh, M. Wintermark, J. English, J. Lam, E. Vittinghoff, W. S. Smith, and S. C. Johnston How Accurate Is CT Angiography in Evaluating Intracranial Atherosclerotic Disease? Stroke, April 1, 2008; 39(4): 1184 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chaturvedi, T. N. Turan, M. J. Lynn, S. E. Kasner, J. Romano, G. Cotsonis, M. Frankel, M. I. Chimowitz, and For the WASID Study Group Risk factor status and vascular events in patients with symptomatic intracranial stenosis Neurology, November 27, 2007; 69(22): 2063 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Williams, M. I. Chimowitz, G. A. Cotsonis, M. J. Lynn, S. P. Waddy, and for the WASID Investigators Gender Differences in Outcomes Among Patients With Symptomatic Intracranial Arterial Stenosis Stroke, July 1, 2007; 38(7): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Wong, Y. N. Huang, H. B. Yang, S. Gao, H. Li, J. Y. Liu, Y. Liu, and A. Tang A door-to-door survey of intracranial atherosclerosis in Liangbei County, China Neurology, June 5, 2007; 68(23): 2031 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Wong, P. W. Ng, A. Tang, R. Liu, V. Yeung, and B. Tomlinson Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients Neurology, June 5, 2007; 68(23): 2035 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weimar, M. Goertler, L. Harms, H.-C. Diener, and for the German Stroke Study Collaboration Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol, September 1, 2006; 63(9): 1287 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mazighi, R. Tanasescu, X. Ducrocq, E. Vicaut, S. Bracard, E. Houdart, and F. Woimant Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA Study Neurology, April 25, 2006; 66(8): 1187 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Kwon, Y.-J. Cho, J.-S. Koo, H.-J. Bae, Y.-S. Lee, K.-S. Hong, J. H. Lee, and J. S. Kim Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis Stroke, April 1, 2005; 36(4): 782 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Koroshetz Warfarin, Aspirin, and Intracranial Vascular Disease N. Engl. J. Med., March 31, 2005; 352(13): 1368 - 1370. [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, J. Alvarez-Sabin, J. Montaner, A. Rosell, C. A. Molina, A. Rovira, M. Ribo, E. Sanchez, and M. Quintana Angiogenesis in Symptomatic Intracranial Atherosclerosis: Predominance of the Inhibitor Endostatin Is Related to a Greater Extent and Risk of Recurrence Stroke, January 1, 2005; 36(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Arenillas, C. A. Molina, P. Chacon, A. Rovira, J. Montaner, P. Coscojuela, E. Sanchez, M. Quintana, and J. Alvarez-Sabin High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis Neurology, July 13, 2004; 63(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|